Login

Dr. Xiaoke (Ken) Liu, Cardiologist 00:00:00

Share On Facebook Share On Twitter

Athletes & Heart Health: Ask Mayo Clinic Health System

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
synthesize engineering with physical and life sciences to create technologies that disrupt global conventions|Benjamin Quiroga,General Partner,Humboldt Fund
00:10:00
IDENTIFYING UNDERUTILISED MOLECULES|PAUL RENNIE,MANAGING DIRECTOR,Paradigm Biopharmaceuticals Ltd
00:10:00
Re-Underwriting Bridgewater's Culture: Co-CEO Nir Bar Dea Discusses Evolving an Idea Meritocratic Environment Amidst Generational Transition
00:10:00
Agilyx CEO Tim Stedman discusses the Portland-based group's new partnerships and initiatives in an interview with Proactive New York.
00:10:00
Presentation on Ariana Resources: Gold Exploration, Development, and Production in Turkey
00:10:00
Update on Asante Gold: Refurbishment Progress and Future Production Expectations
00:10:00
Ed Harrison discusses the insights from Isentia's Leadership Index on the impact of presence following the Sydney launch event.|Edward John Harrison ceo of iSentia Group Ltd.
00:10:00
Pro Bono Promotion: Debevoise & Plimpton LLP Video by MultiVision Digital | Eli Whitney Debevoise - Co Founder of Debevoise & Plimpton LLP
00:10:00
Electrica SA's General Manager Corina Popescu to Go Undercover in Her Own Company | Georgeta Corina Popescu, CEO , Societatea Energetica Electrica SA.
00:10:00
Navigating Social Security, Medicare & Health Care: Insights from Voyager Wealth Management LLC
00:10:00
Mountain Boy Minerals' CEO Shares Promising Updates on Telegraph Project | Lawrence Roulston - President & CEO of MTB Metals Corp.
00:10:00
Huntsville Hospital is a community-based, not-for-profit hospital|David Spillers, chief executive officer of the Huntsville Hospital

© 2026 Nehu